Browse Tag

ChAdOx1 nCoV-2019

Oxford University breakthrough on global COVID-19 vaccine

4 mins read

The FINANCIAL -- The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection. …